Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more


The latest news for pharma industry insiders.

What Digital Technologies are Being Used to Enhance Clinical Trial Enrollment and Diversity?

Systematic review of research articles sought to identify and characterize different technologies being used in clinical studies.

7% of Patients with Cancer Participate in Treatment Research

New study finds trial enrollment was highest at NCI-designated cancer centers. Researchers said more needs to be done to enroll patients from community cancer sites.

Generative AI Isn’t Ubiquitous in the Business World—at Least Not Yet

ChatGPT and other tools have racked up users, but some companies are proceeding with caution, or not at all

Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists

New Bayer innovation platform will help organizations build AI-powered apps that assist radiologists, reducing burnout and supporting more efficient diagnoses

@WHO on X:

3500 people dying globally due to hepatitis B and C infections every day: 2024 Global Hepatitis Report #Hepatitis is the second leading infectious cause of death globally -- with 1.3 million deaths per year

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.